{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:26:48Z","timestamp":1785554808225,"version":"3.56.0"},"reference-count":88,"publisher":"Keio Journal of Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Keio J. Med.","Keio j. med"],"published-print":{"date-parts":[[2021]]},"DOI":"10.2302\/kjm.2020-0006-oa","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T18:10:15Z","timestamp":1593540615000},"page":"7-18","source":"Crossref","is-referenced-by-count":8,"title":["Recent Advances in the Definition and Management of Functional Dyspepsia"],"prefix":"10.2302","volume":"70","author":[{"given":"Hidekazu","family":"Suzuki","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1082","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Drossman DA: Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology 2016; 150: 1262\u20131279.e2. PMID:27144617, DOI:10.1053\/j.gastro.2016.02.032","DOI":"10.1053\/j.gastro.2016.02.032"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Drossman DA: The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 1377\u20131390. PMID:16678553, DOI:10.1053\/j.gastro.2006.03.008","DOI":"10.1053\/j.gastro.2006.03.008"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, Tack J, Talley NJ: Gastroduodenal disorders. Gastroenterology 2016; 150: 1380\u20131392. PMID:27147122, DOI:10.1053\/j.gastro.2016.02.011","DOI":"10.1053\/j.gastro.2016.02.011"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V: Functional gastroduodenal disorders. Gastroenterology 2006; 130: 1466\u20131479. PMID:16678560, DOI:10.1053\/j.gastro.2005.11.059","DOI":"10.1053\/j.gastro.2005.11.059"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Matsuzaki J, Suzuki H, Asakura K, Fukushima Y, Inadomi JM, Takebayashi T, Hibi T: Classification of functional dyspepsia based on concomitant bowel symptoms. Neurogastroenterol Motil 2012; 24: 325\u2013e164. PMID:22235936, DOI:10.1111\/j.1365-2982.2011.01859.x","DOI":"10.1111\/j.1365-2982.2011.01859.x"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Carbone F, Holvoet L, Tack J: Rome III functional dyspepsia subdivision in PDS and EPS: recognizing postprandial symptoms reduces overlap. Neurogastroenterol Motil 2015; 27: 1069\u20131074. PMID:26220647, DOI:10.1111\/nmo.12585","DOI":"10.1111\/nmo.12585"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ: Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol 2007; 102: 1983\u20131989. PMID:17581264, DOI:10.1111\/j.1572-0241.2007.01381.x","DOI":"10.1111\/j.1572-0241.2007.01381.x"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Matsuzaki J, Suzuki H, Fukushima Y, Hirata K, Fukuhara S, Okada S, Hibi T: High frequency of overlap between functional dyspepsia and overactive bladder. Neurogastroenterol Motil 2012; 24: 821\u2013827. PMID:22616664, DOI:10.1111\/j.1365-2982.2012.01939.x","DOI":"10.1111\/j.1365-2982.2012.01939.x"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Ghoshal UC, Singh R: Frequency and risk factors of functional gastro-intestinal disorders in a rural Indian population. J Gastroenterol Hepatol 2017; 32: 378\u2013387. PMID:27262283, DOI:10.1111\/jgh.13465","DOI":"10.1111\/jgh.13465"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Tack J, Talley NJ: Functional dyspepsia-symptoms, definitions and validity of the Rome III criteria. Nat Rev Gastroenterol Hepatol 2013; 10: 134\u2013141. PMID:23399526, DOI:10.1038\/nrgastro.2013.14","DOI":"10.1038\/nrgastro.2013.14"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Brook RA, Kleinman NL, Choung RS, Melkonian AK, Smeeding JE, Talley NJ: Functional dyspepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol 2010; 8: 498\u2013503. PMID:20304102, DOI:10.1016\/j.cgh.2010.03.003","DOI":"10.1016\/j.cgh.2010.03.003"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Lacy BE, Weiser KT, Kennedy AT, Crowell MD, Talley NJ: Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther 2013; 38: 170\u2013177. PMID:23725230, DOI:10.1111\/apt.12355","DOI":"10.1111\/apt.12355"},{"key":"13","unstructured":"13. Bytzer P, Langkilde LK, Christensen E, Meineche-Schmidt V: Work productivity improvement after acid suppression in patients with uninvestigated dyspepsia. Dan Med J 2012; 59: A4461. PMID:22759841"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Vakil N, Stelwagon M, Shea EP, Miller S: Symptom burden and consulting behavior in patients with overlapping functional disorders in the US population. United European Gastroenterol J 2016; 4: 413\u2013422. PMID:27403308, DOI:10.1177\/2050640615600114","DOI":"10.1177\/2050640615600114"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Matsuzaki J, Suzuki H, Togawa K, Yamane T, Mori H, Komori T, Masaoka T, Kanai T: Burden of impaired sleep quality on work productivity in functional dyspepsia. United European Gastroenterol J 2018; 6: 398\u2013406. PMID:29774153, DOI:10.1177\/2050640617726466","DOI":"10.1177\/2050640617726466"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17. Moayyedi P, Soo S, Deeks J, Forman D, Mason J, Innes M, Delaney B, Dyspepsia Review Group: Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. BMJ 2000; 321: 659\u2013664. PMID:10987767, DOI:10.1136\/bmj.321.7262.659","DOI":"10.1136\/bmj.321.7262.659"},{"key":"17","doi-asserted-by":"publisher","unstructured":"18. Zhao B, Zhao J, Cheng WF, Shi WJ, Liu W, Pan XL, Zhang GX: Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up. J Clin Gastroenterol 2014; 48: 241\u2013247. PMID:24002127, DOI:10.1097\/MCG.0b013e31829f2e25","DOI":"10.1097\/MCG.0b013e31829f2e25"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19.Suzuki H, Nishizawa T, and Hibi T: Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia? J Gastroenterol Hepatol 2011; 26 Suppl 3 : 42\u201345","DOI":"10.1111\/j.1440-1746.2011.06629.x"},{"key":"19","doi-asserted-by":"publisher","unstructured":"20. Suzuki H, Matsuzaki J, Hibi T: What is the difference between Helicobacter pylori-associated dyspepsia and functional dyspepsia? J Neurogastroenterol Motil 2011; 17: 124\u2013130. PMID:21602988, DOI:10.5056\/jnm.2011.17.2.124","DOI":"10.5056\/jnm.2011.17.2.124"},{"key":"20","doi-asserted-by":"publisher","unstructured":"21. Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, Haruma K, Asaka M, Uemura N, Malfertheiner P, faculty members of Kyoto Global Consensus Conference: Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015; 64: 1353\u20131367. PMID:26187502, DOI:10.1136\/gutjnl-2015-309252","DOI":"10.1136\/gutjnl-2015-309252"},{"key":"21","doi-asserted-by":"publisher","unstructured":"22. Suzuki H, Mori H: Helicobacter pylori gastritis-a novel distinct disease entity. Nat Rev Gastroenterol Hepatol 2015; 12: 556\u2013557. PMID:26369312, DOI:10.1038\/nrgastro.2015.158","DOI":"10.1038\/nrgastro.2015.158"},{"key":"22","doi-asserted-by":"publisher","unstructured":"23. Suzuki H, Iwasaki E, Hibi T: Helicobacter pylori and gastric cancer. Gastric Cancer 2009; 12: 79\u201387. PMID:19562461, DOI:10.1007\/s10120-009-0507-x","DOI":"10.1007\/s10120-009-0507-x"},{"key":"23","doi-asserted-by":"publisher","unstructured":"24. Chen SL, Gwee KA, Lee JS, Miwa H, Suzuki H, Guo P, Hao YT, Chen MH: Systematic review with meta-analysis: prompt endoscopy as the initial management strategy for uninvestigated dyspepsia in Asia. Aliment Pharmacol Ther 2015; 41: 239\u2013252. PMID:25429769, DOI:10.1111\/apt.13028","DOI":"10.1111\/apt.13028"},{"key":"24","doi-asserted-by":"publisher","unstructured":"25. Miwa H, Kusano M, Arisawa T, Oshima T, Kato M, Joh T, Suzuki H, Tominaga K, Nakada K, Nagahara A, Futagami S, Manabe N, Inui A, Haruma K, Higuchi K, Yakabi K, Hongo M, Uemura N, Kinoshita Y, Sugano K, Shimosegawa T, Japanese Society of Gastroenterology: Evidence-based clinical practice guidelines for functional dyspepsia. J Gastroenterol 2015; 50: 125\u2013139. PMID:25586651, DOI:10.1007\/s00535-014-1022-3","DOI":"10.1007\/s00535-014-1022-3"},{"key":"25","doi-asserted-by":"publisher","unstructured":"26. Mahadeva S, Chia YC, Vinothini A, Mohazmi M, Goh KL: Cost-effectiveness of and satisfaction with a Helicobacter pylori \u201ctest and treat\u201d strategy compared with prompt endoscopy in young Asians with dyspepsia. Gut 2008; 57: 1214\u20131220. PMID:18441005, DOI:10.1136\/gut.2007.147728","DOI":"10.1136\/gut.2007.147728"},{"key":"26","doi-asserted-by":"publisher","unstructured":"27. Kawamura Y, Funaki Y, Yoshimine T, Tamura Y, Yamamoto S, Izawa S, Hayakawa T, Ebi M, Murotani K, Ogasawara N, Sasaki M, Kasugai K: Characteristics and predictive factor of Helicobacter pylori-associated functional dyspepsia in Japanese patients. Digestion 2019; 100: 277\u2013285. PMID:30630185, DOI:10.1159\/000496101","DOI":"10.1159\/000496101"},{"key":"27","doi-asserted-by":"publisher","unstructured":"28. Matsuzaki J, Tsugawa H, Kashiwazaki Y, Mori H, Yamamoto Y, Kameyama H, Masaoka T, Kanai T, Suzuki H: Neutrophil-activating protein polymorphism of Helicobacter pylori determines the host risk of dyspepsia. Cell Mol Gastroenterol Hepatol 2019; 8: 295\u2013297.e6. PMID:31108232, DOI:10.1016\/j.jcmgh.2019.05.004","DOI":"10.1016\/j.jcmgh.2019.05.004"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J: Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115: 1346\u20131352. PMID:9834261, DOI:10.1016\/S0016-5085(98)70012-5","DOI":"10.1016\/S0016-5085(98)70012-5"},{"key":"29","doi-asserted-by":"publisher","unstructured":"30. Tack J, Caenepeel P, Piessevaux H, Cuomo R, Janssens J: Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia. Gut 2003; 52: 1271\u20131277. PMID:12912857, DOI:10.1136\/gut.52.9.1271","DOI":"10.1136\/gut.52.9.1271"},{"key":"30","doi-asserted-by":"publisher","unstructured":"31. Tack J, Demedts I, Meulemans A, Schuurkes J, Janssens J: Role of nitric oxide in the gastric accommodation reflex and in meal induced satiety in humans. Gut 2002; 51: 219\u2013224. PMID:12117883, DOI:10.1136\/gut.51.2.219","DOI":"10.1136\/gut.51.2.219"},{"key":"31","doi-asserted-by":"publisher","unstructured":"32. Karamanolis G, Caenepeel P, Arts J, Tack J: Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology 2006; 130: 296\u2013303. PMID:16472585, DOI:10.1053\/j.gastro.2005.10.019","DOI":"10.1053\/j.gastro.2005.10.019"},{"key":"32","doi-asserted-by":"publisher","unstructured":"33. Vijayvargiya P, Camilleri M, Chedid V, Mandawat A, Erwin PJ, Murad MH: Effects of promotility agents on gastric emptying and symptoms: a systematic review and meta-analysis. Gastroenterology 2019; 156: 1650\u20131660. PMID:30711628, DOI:10.1053\/j.gastro.2019.01.249","DOI":"10.1053\/j.gastro.2019.01.249"},{"key":"33","doi-asserted-by":"crossref","unstructured":"34. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J: Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121: 526\u2013535. PMID:11522735, DOI:10.1053\/gast.2001.27180","DOI":"10.1053\/gast.2001.27180"},{"key":"34","doi-asserted-by":"publisher","unstructured":"35. Vandenberghe J, Vos R, Persoons P, Demyttenaere K, Janssens J, Tack J: Dyspeptic patients with visceral hypersensitivity: sensitisation of pain specific or multimodal pathways? Gut 2005; 54: 914\u2013919. PMID:15951533, DOI:10.1136\/gut.2004.052605","DOI":"10.1136\/gut.2004.052605"},{"key":"35","doi-asserted-by":"publisher","unstructured":"36. Farr\u00e9 R, Vanheel H, Vanuytsel T, Masaoka T, T\u00f6rnblom H, Simr\u00e9n M, Van Oudenhove L, Tack JF: In functional dyspepsia, hypersensitivity to postprandial distention correlates with meal-related symptom severity. Gastroenterology 2013; 145: 566\u2013573. PMID:23702005, DOI:10.1053\/j.gastro.2013.05.018","DOI":"10.1053\/j.gastro.2013.05.018"},{"key":"36","doi-asserted-by":"publisher","unstructured":"37. Wauters L, Talley NJ, Walker MM, Tack J, Vanuytsel T: Novel concepts in the pathophysiology and treatment of functional dyspepsia. Gut 2020; 69: 591\u2013600. PMID:PMID:31784469, , DOI:10.1136\/gutjnl-2019-318536","DOI":"10.1136\/gutjnl-2019-318536"},{"key":"37","doi-asserted-by":"publisher","unstructured":"38. Samsom M, Verhagen MA, vanBerge Henegouwen GP, Smout AJ: Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology 1999; 116: 515\u2013520. PMID:10029608, DOI:10.1016\/S0016-5085(99)70171-X","DOI":"10.1016\/S0016-5085(99)70171-X"},{"key":"38","doi-asserted-by":"publisher","unstructured":"39. Oshima T, Okugawa T, Tomita T, Sakurai J, Toyoshima F, Watari J, Yamaguchi K, Fujimoto K, Adachi K, Kinoshita Y, Kusunoki H, Haruma K, Miwa H: Generation of dyspeptic symptoms by direct acid and water infusion into the stomachs of functional dyspepsia patients and healthy subjects. Aliment Pharmacol Ther 2012; 35: 175\u2013182. PMID:22085402, DOI:10.1111\/j.1365-2036.2011.04918.x","DOI":"10.1111\/j.1365-2036.2011.04918.x"},{"key":"39","doi-asserted-by":"publisher","unstructured":"40. Lee KJ, Vos R, Janssens J, Tack J: Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans. Am J Physiol Gastrointest Liver Physiol 2004; 286: G278\u2013G284. PMID:12760903, DOI:10.1152\/ajpgi.00086.2003","DOI":"10.1152\/ajpgi.00086.2003"},{"key":"40","doi-asserted-by":"publisher","unstructured":"41. Hammer J, Vogelsang Characterization of sensations induced by capsaicin in the upper gastrointestinal tract. Neurogastroenterol Motil 2007; 19: 279\u2013287. PMID:17391244, DOI:10.1111\/j.1365-2982.2007.00900.x","DOI":"10.1111\/j.1365-2982.2007.00900.x"},{"key":"41","doi-asserted-by":"publisher","unstructured":"42. Lee SY, Masaoka T, Han HS, Matsuzaki J, Hong MJ, Fukuhara S, Choi HS, Suzuki H: A prospective study on symptom generation according to spicy food intake and TRPV1 genotypes in functional dyspepsia patients. Neurogastroenterol Motil 2016; 28: 1401\u20131408. PMID:27094759, DOI:10.1111\/nmo.12841","DOI":"10.1111\/nmo.12841"},{"key":"42","doi-asserted-by":"publisher","unstructured":"43. Vanuytsel T, Vanormelingen C, Vanheel H, Masaoka T, Salim Rasoel S, T\u00f3th J, Houben E, Verbeke K, De Hertogh G, Berghe PV, Tack J, Farr\u00e9 R: From intestinal permeability to dysmotility: the biobreeding rat as a model for functional gastrointestinal disorders. PLoS One 2014; 9: e111132. PMID:25354336, DOI:10.1371\/journal.pone.0111132","DOI":"10.1371\/journal.pone.0111132"},{"key":"43","doi-asserted-by":"publisher","unstructured":"45. Ronkainen J, Aro P, Walker MM, Agr\u00e9us L, Johansson SE, Jones M, Talley NJ: Duodenal eosinophilia is associated with functional dyspepsia and new onset gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2019; 50: 24\u201332. PMID:31107579, DOI:10.1111\/apt.15308","DOI":"10.1111\/apt.15308"},{"key":"44","doi-asserted-by":"publisher","unstructured":"46. Zhong L, Shanahan ER, Raj A, Koloski NA, Fletcher L, Morrison M, Walker MM, Talley NJ, Holtmann G: Dyspepsia and the microbiome: time to focus on the small intestine. Gut 2017; 66: 1168\u20131169. PMID:27489239, DOI:10.1136\/gutjnl-2016-312574","DOI":"10.1136\/gutjnl-2016-312574"},{"key":"45","doi-asserted-by":"publisher","unstructured":"47. Pavlidis P, Powell N, Vincent RP, Ehrlich D, Bjarnason I, Hayee B: Systematic review: bile acids and intestinal inflammation \u2013 luminal aggressors or regulators of mucosal defence? Aliment Pharmacol Ther 2015; 42: 802\u2013817. PMID:26223936, DOI:10.1111\/apt.13333","DOI":"10.1111\/apt.13333"},{"key":"46","doi-asserted-by":"publisher","unstructured":"48. Beeckmans D, Riethorst D, Augustijns P, Vanuytsel T, Farr\u00e9 R, Tack J, Vanheel H: Altered duodenal bile salt concentration and receptor expression in functional dyspepsia. United European Gastroenterol J 2018; 6: 1347\u20131355. PMID:30386607, DOI:10.1177\/2050640618799120","DOI":"10.1177\/2050640618799120"},{"key":"47","doi-asserted-by":"publisher","unstructured":"49. Rodi\u00f1o-Janeiro BK, Alonso-Cotoner C, Pigrau M, Lobo B, Vicario M, Santos J: Role of corticotropin-releasing factor in gastrointestinal permeability. J Neurogastroenterol Motil 2015; 21: 033\u2013050. PMID:25537677, DOI:10.5056\/jnm14084","DOI":"10.5056\/jnm14084"},{"key":"48","doi-asserted-by":"publisher","unstructured":"50. Zheng PY, Feng BS, Oluwole C, Struiksma S, Chen X, Li P, Tang SG, Yang PC: Psychological stress induces eosinophils to produce corticotrophin releasing hormone in the intestine. Gut 2009; 58: 1473\u20131479. PMID:19651632, DOI:10.1136\/gut.2009.181701","DOI":"10.1136\/gut.2009.181701"},{"key":"49","doi-asserted-by":"publisher","unstructured":"51. Liu P, Fan Y, Wei Y, Zeng F, Li R, Fei N, Qin W: Altered structural and functional connectivity of the insula in functional dyspepsia. Neurogastroenterol Motil 2018; 30: e13345. PMID:29687532, DOI:10.1111\/nmo.13345","DOI":"10.1111\/nmo.13345"},{"key":"50","doi-asserted-by":"publisher","unstructured":"52. Chen Y, Wang R, Hou B, Feng F, Fang X, Zhu L, Sun X, Wang Z, Ke M: Regional brain activity during rest and gastric water load in subtypes of functional dyspepsia: a preliminary brain functional magnetic resonance imaging study. J Neurogastroenterol Motil 2018; 24: 268\u2013279. PMID:29605982, DOI:10.5056\/jnm17076","DOI":"10.5056\/jnm17076"},{"key":"51","doi-asserted-by":"publisher","unstructured":"53. Strandwitz P, Kim KH, Terekhova D, Liu JK, Sharma A, Levering J, McDonald D, Dietrich D, Ramadhar TR, Lekbua A, Mroue N, Liston C, Stewart EJ, Dubin MJ, Zengler K, Knight R, Gilbert JA, Clardy J, Lewis K: GABA-modulating bacteria of the human gut microbiota. Nat Microbiol 2019; 4: 396\u2013403. PMID:30531975, DOI:10.1038\/s41564-018-0307-3","DOI":"10.1038\/s41564-018-0307-3"},{"key":"52","doi-asserted-by":"crossref","unstructured":"54.Mertens KL, Kalsbeek A, Soeters MR, Eggink HM: Bile acid signaling pathways from the enterohepatic circulation to the central nervous system. Front Neurosci 2017; 11 : 617","DOI":"10.3389\/fnins.2017.00617"},{"key":"53","doi-asserted-by":"publisher","unstructured":"55. Sahai AV, Mishra G, Penman ID, Williams D, Wallace MB, Hadzijahic N, Pearson A, VanVelse A, Hoffman BJ, Hawes RH: EUS to detect evidence of pancreatic disease in patients with persistent or nonspecific dyspepsia. Gastrointest Endosc 2000; 52: 153\u2013159. PMID:10922084, DOI:10.1067\/mge.2000.107910","DOI":"10.1067\/mge.2000.107910"},{"key":"54","doi-asserted-by":"crossref","unstructured":"56. Smith RC, Talley NJ, Dent OF, Jones M, Waller SL: Exocrine pancreatic function and chronic unexplained dyspepsia. A case-control study. Int J Pancreatol 1991; 8: 253\u2013262. PMID:2051063","DOI":"10.1007\/BF02924544"},{"key":"55","doi-asserted-by":"publisher","unstructured":"57. Ito T, Ishiguro H, Ohara H, Kamisawa T, Sakagami J, Sata N, Takeyama Y, Hirota M, Miyakawa H, Igarashi H, Lee L, Fujiyama T, Hijioka M, Ueda K, Tachibana Y, Sogame Y, Yasuda H, Kato R, Kataoka K, Shiratori K, Sugiyama M, Okazaki K, Kawa S, Tando Y, Kinoshita Y, Watanabe M, Shimosegawa T: Evidence-based clinical practice guidelines for chronic pancreatitis 2015. J Gastroenterol 2016; 51: 85\u201392. PMID:26725837, DOI:10.1007\/s00535-015-1149-x","DOI":"10.1007\/s00535-015-1149-x"},{"key":"56","doi-asserted-by":"publisher","unstructured":"58. Wakabayashi M, Futagami S, Yamawaki H, Tatsuguchi A, Kaneko K, Agawa S, Higuchi K, Sakasegawa N, Murakami M, Akimoto T, Kodaka Y, Ueki N, Gudis K, Kawamoto C, Akamizu T, Sakamoto C, Iwakiri K: Comparison of clinical symptoms, gastric motility and fat intake in the early chronic pancreatitis patients with anti-acid therapy-resistant functional dyspepsia patients. PLoS One 2018; 13: e0205165. PMID:30403664, DOI:10.1371\/journal.pone.0205165","DOI":"10.1371\/journal.pone.0205165"},{"key":"57","doi-asserted-by":"publisher","unstructured":"59. Yamawaki H, Futagami S, Kaneko K, Agawa S, Higuchi K, Murakami M, Wakabayashi M, Sakasegawa N, Kodaka Y, Ueki N, Gudis K, Kawamoto C, Iwakiri K: Camostat mesilate, pancrelipase, and rabeprazole combination therapy improves epigastric pain in early chronic pancreatitis and functional dyspepsia with pancreatic enzyme abnormalities. Digestion 2019; 99: 283\u2013292. PMID:30391941, DOI:10.1159\/000492813","DOI":"10.1159\/000492813"},{"key":"58","doi-asserted-by":"publisher","unstructured":"60. Garnock-Jones KP: Vonoprazan: first global approval. Drugs 2015; 75: 439\u2013443. PMID:25744862, DOI:10.1007\/s40265-015-0368-z","DOI":"10.1007\/s40265-015-0368-z"},{"key":"59","doi-asserted-by":"publisher","unstructured":"61. Takahashi N, Take Y: Tegoprazan, a novel potassium-competitive acid blocker to control gastric acid secretion and motility. J Pharmacol Exp Ther 2018; 364: 275\u2013286. PMID:29180359, DOI:10.1124\/jpet.117.244202","DOI":"10.1124\/jpet.117.244202"},{"key":"60","doi-asserted-by":"publisher","unstructured":"62. Suzuki H, Matsuzaki J, Fukushima Y, Suzaki F, Kasugai K, Nishizawa T, Naito Y, Hayakawa T, Kamiya T, Andoh T, Yoshida H, Tokura Y, Nagata H, Kobayakawa M, Mori M, Kato K, Hosoda H, Takebayashi T, Miura S, Uemura N, Joh T, Hibi T, Tack J, Rikkunshito study group: Randomized clinical trial: rikkunshito in the treatment of functional dyspepsia \u2013 a multicenter, double-blind, randomized, placebo-controlled study. Neurogastroenterol Motil 2014; 26: 950\u2013961. PMID:24766295, DOI:10.1111\/nmo.12348","DOI":"10.1111\/nmo.12348"},{"key":"61","doi-asserted-by":"publisher","unstructured":"63. Xiao Y, Li Y, Shu J, Li Y, Xu J, Ren J, Liu D, Wang J, Zhou L, Li Y, Tang G, Tian D, Zhang S, Hou X, Wang H, Li Z, Lv N, Chen M: The efficacy of oral Zhizhu Kuanzhong, a traditional Chinese medicine, in patients with postprandial distress syndrome. J Gastroenterol Hepatol 2019; 34: 526\u2013531. PMID:30207000, DOI:10.1111\/jgh.14467","DOI":"10.1111\/jgh.14467"},{"key":"62","doi-asserted-by":"publisher","unstructured":"64. Shahbazkhani B, Fanaeian MM, Farahvash MJ, Aletaha N, Alborzi F, Elli L, Shahbazkhani A, Zebardast J, Rostami-Nejad M: Prevalence of non-celiac gluten sensitivity in patients with refractory functional dyspepsia: a randomized double-blind placebo controlled trial. Sci Rep 2020; 10: 2401. PMID:32051513, DOI:10.1038\/s41598-020-59532-z","DOI":"10.1038\/s41598-020-59532-z"},{"key":"63","doi-asserted-by":"crossref","unstructured":"65.Pinto-Sanchez MI, Yuan Y, Bercik P, Moayyedi P: Proton pump inhibitors for functional dyspepsia. Cochrane Database Syst Rev 2017; 11 : CD011194.","DOI":"10.1002\/14651858.CD011194.pub3"},{"key":"64","doi-asserted-by":"publisher","unstructured":"66. Suzuki H, Kusunoki H, Kamiya T, Futagami S, Yamaguchi Y, Nishizawa T, Iwasaki E, Matsuzaki J, Takahashi S, Sakamoto C, Haruma K, Joh T, Asakura K, Hibi T: Effect of lansoprazole on the epigastric symptoms of functional dyspepsia (ELF study): a multicentre, prospective, randomized, double-blind, placebo-controlled clinical trial. United European Gastroenterol J 2013; 1: 445\u2013452. PMID:24917996, DOI:10.1177\/2050640613510904","DOI":"10.1177\/2050640613510904"},{"key":"65","doi-asserted-by":"crossref","unstructured":"67. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D: Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006; 18: CD001960. PMID:17054151","DOI":"10.1002\/14651858.CD001960.pub3"},{"key":"66","doi-asserted-by":"publisher","unstructured":"68. Talley NJ, Vakil NB, Moayyedi P: American Gastroenterological Association technical review on the evaluation of dyspepsia. Gastroenterology 2005; 129: 1756\u20131780. PMID:16285971, DOI:10.1053\/j.gastro.2005.09.020","DOI":"10.1053\/j.gastro.2005.09.020"},{"key":"67","doi-asserted-by":"publisher","unstructured":"69. Matsueda K, Hongo M, Tack J, Saito Y, Kato H: A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut 2012; 61: 821\u2013828. PMID:22157329, DOI:10.1136\/gutjnl-2011-301454","DOI":"10.1136\/gutjnl-2011-301454"},{"key":"68","doi-asserted-by":"publisher","unstructured":"70. Matsueda K, Hongo M, Ushijima S, Akiho H: A long-term study of acotiamide in patients with functional dyspepsia: results from an open-label phase III trial in Japan on efficacy, safety and pattern of administration. Digestion 2011; 84: 261\u2013268. PMID:21934307, DOI:10.1159\/000332404","DOI":"10.1159\/000332404"},{"key":"69","unstructured":"71.Ueda M, Iwasaki E, Suzuki H: Profile of acotiamide in the treatment of functional dyspepsia. Clin Exp Gastroenterol 2016; 9 : 83\u201388."},{"key":"70","doi-asserted-by":"publisher","unstructured":"72. Sarvepalli D, Rashid MU, Ullah W, Zafar Y, Khan AH: Postsurgical refractory gastroparesis: response to botulinum toxin therapy. Cureus 2020; 12: e6596. PMID:32064178, DOI:10.7759\/cureus.6596","DOI":"10.7759\/cureus.6596"},{"key":"71","doi-asserted-by":"publisher","unstructured":"73. Tack J, Van den Houte K, Carbone F: Gastroduodenal motility disorders. Curr Opin Gastroenterol 2018; 34: 428\u2013435. PMID:30199408, DOI:10.1097\/MOG.0000000000000473","DOI":"10.1097\/MOG.0000000000000473"},{"key":"72","doi-asserted-by":"publisher","unstructured":"74. Carbone F, Van den Houte K, Clevers E, Andrews CN, Papathanasopoulos A, Holvoet L, Van Oudenhove L, Caenepeel P, Arts J, Vanuytsel T, Tack J: Prucalopride in gastroparesis. Am J Gastroenterol 2019; 114: 1265\u20131274. PMID:31295161, DOI:10.14309\/ajg.0000000000000304","DOI":"10.14309\/ajg.0000000000000304"},{"key":"73","doi-asserted-by":"crossref","unstructured":"75.Tack J, Camilleri M: New developments in the treatment of gastroparesis and functional dyspepsia. Curr Opin Pharmacol 2018; 43 :111\u2013117.","DOI":"10.1016\/j.coph.2018.08.015"},{"key":"74","doi-asserted-by":"crossref","unstructured":"76.Camilleri M, McCallum RW, Tack J, Spence SC, Gottesdiener K, Fiedorek FT: Efficacy and safety of relamorelin in diabetics with symptoms of gastroparesis: a randomized, placebo-controlled study. Gastroenterology 2017; 153(5): 1240\u20131250 e2","DOI":"10.1053\/j.gastro.2017.07.035"},{"key":"75","doi-asserted-by":"publisher","unstructured":"77. Staller K, Thurler AH, Reynolds JS, Dimisko LR, McGovern R, Skarbinski KF, Kuo B: Gabapentin improves symptoms of functional dyspepsia in a retrospective, open-label cohort study. J Clin Gastroenterol 2019; 53: 379\u2013384. PMID:29668559, DOI:10.1097\/MCG.0000000000001034","DOI":"10.1097\/MCG.0000000000001034"},{"key":"76","doi-asserted-by":"crossref","unstructured":"78. Miwa H, Nagahara A, Tominaga K, Yokoyama T, Sawada Y, Inoue K, Ashida K, Fukuchi T, Hojo M, Yamashita H, Tomita T, Hori K, Oshima T: Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial. Am J Gastroenterol 2009; 104: 2779\u20132787. PMID:19638966, DOI:10.1038\/ajg.2009.427","DOI":"10.1038\/ajg.2009.427"},{"key":"77","doi-asserted-by":"publisher","unstructured":"79. Tack J, Janssen P, Masaoka T, Farr\u00e9 R, Van Oudenhove L: Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clin Gastroenterol Hepatol 2012; 10: 1239\u20131245. PMID:22813445, DOI:10.1016\/j.cgh.2012.06.036","DOI":"10.1016\/j.cgh.2012.06.036"},{"key":"78","doi-asserted-by":"crossref","unstructured":"80.Braden B, Caspary W, Borner N, Vinson B, Schneider AR: Clinical effects of STW 5 (Iberogast) are not based on acceleration of gastric emptying in patients with functional dyspepsia and gastroparesis. Neurogastroenterol Motil 2009; 21(6): 632\u2013638, e25","DOI":"10.1111\/j.1365-2982.2008.01249.x"},{"key":"79","doi-asserted-by":"publisher","unstructured":"81. suzuki , inadomi , hibi Japanese herbal medicine in functional gastrointestinal disorders. Neurogastroenterol Motil 2009; 21: 688\u2013696. PMID:19563404, DOI:10.1111\/j.1365-2982.2009.01290.x","DOI":"10.1111\/j.1365-2982.2009.01290.x"},{"key":"80","doi-asserted-by":"publisher","unstructured":"82. Togawa K, Matsuzaki J, Kobayakawa M, Fukushima Y, Suzaki F, Kasugai K, Nishizawa T, Naito Y, Hayakawa T, Kamiya T, Andoh T, Yoshida H, Tokura Y, Nagata H, Mori M, Kato K, Hosoda H, Takebayashi T, Miura S, Uemura N, Joh T, Hibi T, Suzuki H: Association of baseline plasma des-acyl ghrelin level with the response to rikkunshito in patients with functional dyspepsia. J Gastroenterol Hepatol 2016; 31: 334\u2013341. PMID:26252950, DOI:10.1111\/jgh.13074","DOI":"10.1111\/jgh.13074"},{"key":"81","doi-asserted-by":"publisher","unstructured":"81. suzuki , inadomi , hibi Japanese herbal medicine in functional gastrointestinal disorders. Neurogastroenterol Motil 2009; 21: 688\u2013696. PMID:19563404, DOI:10.1111\/j.1365-2982.2009.01290.x","DOI":"10.1111\/j.1365-2982.2009.01290.x"},{"key":"82","doi-asserted-by":"crossref","unstructured":"84.Talley NJ, Locke GR, Saito YA, Almazar AE, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Prather CM, Abraham BP,et al.: Effect of amitriptyline and escitalopram on functional dyspepsia: a multicenter, randomized controlled study. Gastroenterology 2015; 149 : 340\u2013349 e2","DOI":"10.1053\/j.gastro.2015.04.020"},{"key":"83","doi-asserted-by":"publisher","unstructured":"85. Daneshjoo R, Talley NJ: Eosinophilic gastroenteritis. Curr Gastroenterol Rep 2002; 4: 366\u2013372. PMID:12228038, DOI:10.1007\/s11894-002-0006-2","DOI":"10.1007\/s11894-002-0006-2"},{"key":"84","doi-asserted-by":"publisher","unstructured":"86. Youngblood BA, Brock EC, Leung J, Falahati R, Bochner BS, Rasmussen HS, Peterson K, Bebbington C, Tomasevic N: Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis. JCI Insight 2019; 4: e126219. PMID:31465299, DOI:10.1172\/jci.insight.126219","DOI":"10.1172\/jci.insight.126219"},{"key":"85","doi-asserted-by":"publisher","unstructured":"87. Wang Y, Hou YQ, Yang JW, Wang LQ, Shao JK, Zou X, Yang NN, Huang J, Liu CZ: Acupuncture of different treatment frequency in postprandial distress syndrome: a pilot randomized clinical trial. Neurogastroenterol Motil 2020; 32: e13812. PMID:32048788, DOI:10.1111\/nmo.13812","DOI":"10.1111\/nmo.13812"},{"key":"86","doi-asserted-by":"publisher","unstructured":"88. Suzuki H, Nishizawa T, Hibi T: Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification. J Gastroenterol 2006; 41: 513\u2013523. PMID:16868798, DOI:10.1007\/s00535-006-1847-5","DOI":"10.1007\/s00535-006-1847-5"},{"key":"87","doi-asserted-by":"crossref","unstructured":"89.Hemmink GJ, Ten Cate L, Bredenoord AJ, Timmer R, Weusten BL, Smout AJ: Speech therapy in patients with excessive supragastric belching \u2013 a pilot study. Neurogastroenterol Motil 2010; 22(1) : 24\u20138, e2-3","DOI":"10.1111\/j.1365-2982.2009.01371.x"},{"key":"88","doi-asserted-by":"publisher","unstructured":"90. Grover M, Dasari S, Bernard CE, Chikkamenahalli LL, Yates KP, Pasricha PJ, Sarosiek I, McCallum R, Koch KL, Abell TL, Kuo B, Shulman RJ, Gibbons SJ, McKenzie TJ, Kellogg TA, Kendrick ML, Tonascia J, Hamilton FA, Parkman HP, Farrugia G: Proteomics in gastroparesis: unique and overlapping protein signatures in diabetic and idiopathic gastroparesis. Am J Physiol Gastrointest Liver Physiol 2019; 317: G716\u2013G726. PMID:31482734, DOI:10.1152\/ajpgi.00115.2019","DOI":"10.1152\/ajpgi.00115.2019"}],"container-title":["The Keio Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/70\/1\/70_2020-0006-OA\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T19:04:44Z","timestamp":1723143884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/70\/1\/70_2020-0006-OA\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2302\/kjm.2020-0006-oa","relation":{},"ISSN":["0022-9717","1880-1293"],"issn-type":[{"value":"0022-9717","type":"print"},{"value":"1880-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}